These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3575001)

  • 1. [Value of perfusion and infusion in the treatment of malignant melanoma of the lower extremities].
    Meyza J
    Pediatr Pol; 1986 Aug; 61(8):521-3. PubMed ID: 3575001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extensive lymphadenectomy and perfusion chemotherapy in the treatment of pigmented skin tumors of the lower extremities].
    Kolesov VI; Levin AO; Martyniuk VV; Sidorenko LN; Stepanova NS
    Vestn Khir Im I I Grek; 1970 Jun; 104(6):68-73. PubMed ID: 4992349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
    Kolessov VI; Levin AO
    Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
    Kam PC; Thompson JF
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)].
    Hafström L; Jönsson PE
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
    Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
    Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
    Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regional chemotherapy of malignant melanoblastomas of the extremities].
    Datsenko BM; Kutsyĭ AS
    Vopr Onkol; 1970; 16(1):22-30. PubMed ID: 4907676
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the morphologic changes in malignant melanomas of the skin during therapy using the method of regional perfusion with chemical preparations].
    Abbasov AT; Parshikova SM
    Arkh Patol; 1966; 28(11):42-5. PubMed ID: 6002050
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perfusion treatment of extremities in malignant melanoma. 9 year experience in 134 patients].
    Nachbur B; von Wattenwyl G; Goldhirsch A
    Helv Chir Acta; 1983 Jan; 49(5):629-32. PubMed ID: 6832996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perfusion of the extremities in malignant melanoma. Indication, technic and results].
    Nagel K; Junginger T
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1626-9. PubMed ID: 3665750
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
    Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
    Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
    Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
    Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.